Although second quarter earnings for St. Jude Medical Inc. (Nasdaq: STJ) rose to 63 cents per share from 55 cents per share a year earlier, revenue dropped to fall short of estimates as sales of implantable cardioverter defibrillators slipped. Shares of the medical device maker tumbled $3.52 to close at $36.08.
Revenue Falls For St. Jude Medical
July 22, 2009 at 17:46 PM EDT
